![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
The item has been added to your shopping cart.
Home » FDA OKs Study of ReCell for Scars
FDA OKs Study of ReCell for Scars
August 31, 2011
The Food and Drug Administration has approved Avita Medical’s investigational device exemption feasibility study for the use of ReCell Spray-On-Skin in the treatment of hypertrophic dyspigmented scars.
Modern Medicine
Modern Medicine
Upcoming Events
-
21Oct